Directing Ricin-based Immunotoxins with Targeting Affibodies and KDEL Signal Peptide to Cancer Cells Effectively Induces Apoptosis and Tumor Suppression

TRAIL & EGFR Affibody Dual-display on a Protein Cage Nanoparticle Synergistically Suppresses Tumor Growth

Target-Switchable Gd(III)-DOTA/Protein Cage Nanoparticle Conjugates with Multiple Targeting Affibody Molecules as Target Selective T1 Contrast Agents for High-field MRI

Selective and Effective Cancer Treatments using Target-Switchable Intracellular Bacterial Toxin Delivery Systems

Engineering Tunable Dual Functional Protein Cage Nanoparticles using Bacterial Superglue

Eom, S., Park, S. G., Jun, H., Kim, Y., Lee, H. B., and Kang, S.,* Effective in vivo delivery of diphtheria toxin using protein cage nanoparticles for targeted cancer therapy.

Kim, Y.,* Mun, J., Kim, E., Roh, H., Eom, S., Jun, H., Kim, H. J., Kim, M., Jeon, J. P., Park, S. H., Min, D.,* and Kang, S.,* Compact clustering of highly oligomerized anti-DR5 nanobodies effectively drives apoptotic cancer cell death, significantly suppressing tumor growth .

Kim, Y.,* Kim, J., Eom, S., Jun, H., Lee, H. B., Jeong, D., and Kang, S.,* Protein Nanoparticles Simultaneously Displaying TRAIL and EGFR-Binding Ligands Effectively Induce Apoptotic Cancer Cell Death and Overcome EGFR-TKI Resistance in Lung Cancer.

Eom, S., Park, S. G., Koo, Y. H., Noh, Y., Choi, C., Kim, Y., Jun, H., Cha, C., Joo, J., and Kang, S.* In Situ Forming and Self-crosslinkable Protein Hydrogels for Localized Cancer Therapy and Topical Wound Healing.

Jun, H., Yeo, M., Jeon, J. P., Eom, S., Kim, H. J., Kim, Y., Jang, E., Park, S. H., Kim, E., and Kang, S.* CD13-targeting and TRAIL-displaying Protein Nanoparticles Effectively Induce Apoptotic Cell Death of Acute Myeloid Leukemia, Prolonging Survival in Mouse Models.